Last reviewed · How we verify
cephalosporin with or without erythromycin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
cephalosporin with or without erythromycin (cephalosporin with or without erythromycin) — Universidad de Granada.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| cephalosporin with or without erythromycin TARGET | cephalosporin with or without erythromycin | Universidad de Granada | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- cephalosporin with or without erythromycin CI watch — RSS
- cephalosporin with or without erythromycin CI watch — Atom
- cephalosporin with or without erythromycin CI watch — JSON
- cephalosporin with or without erythromycin alone — RSS
Cite this brief
Drug Landscape (2026). cephalosporin with or without erythromycin — Competitive Intelligence Brief. https://druglandscape.com/ci/cephalosporin-with-or-without-erythromycin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab